About
Gene Therapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Team (27)
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
618
By Phase
PHASE2: 2PHASE1/PHASE2: 2PHASE1: 1
By Status
ACTIVE_NOT_RECRUITING: 3ENROLLING_BY_INVITATION: 1RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT06544798Lead Sponsor
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
PHASE2Enrolling by invitation
276 participants
Started: Aug 2, 2024 · Completed: Feb 29, 2032
NCT05926765Lead Sponsor
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
PHASE2Recruiting
276 participants
Started: Jun 13, 2023 · Completed: Dec 31, 2026
NCT05894343Lead Sponsor
Long-term Follow-up of Glutamic Acid Decarboxylase (GAD) Gene Transfer in Parkinson's Disease
PHASE1/PHASE2Active, not recruiting
13 participants
Started: May 19, 2023 · Completed: Oct 31, 2029
NCT05603312Lead Sponsor
A Double-blind Study to Evaluate the Safety of Glutamic Acid Decarboxylase Gene Transfer in Parkinson's Participants
PHASE1/PHASE2Completed
14 participants
Started: Oct 5, 2022 · Completed: Sep 6, 2024
NCT05060341Lead Sponsor
Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia
N/AActive, not recruiting
22 participants
Started: Nov 12, 2020 · Completed: Mar 31, 2027
Locations (1)
Headquarters
London, UK
Map
Loading map...